Incarceration status at buprenorphine initiation and OUD treatment outcomes during pregnancy
IntroductionOpioid use disorder (OUD) is a leading cause of pregnancy-associated deaths. OUD treatment with buprenorphine (BUP) reduces overdose risk and improves perinatal outcomes. Incarceration can be a barrier to receipt of OUD treatment during pregnancy and postpartum. The objective of this stu...
Main Authors: | Andrea Nguyen, Hannah Shadowen, Caroline Shadowen, Bhushan Thakkar, Andrea K. Knittel, Caitlin E. Martin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1157611/full |
Similar Items
-
Evaluation of drug-drug interactions in hospitalized patients on medications for OUD
by: Olivia Berger, PharmD, et al.
Published: (2021-07-01) -
Psychiatric comorbidities and their treatment predict buprenorphine continuation among postpartum people with opioid use disorder
by: Hannah Shadowen, et al.
Published: (2022-12-01) -
Low-dose buprenorphine initiation during pregnancy: a case report
by: Shivania Reddy, BSc, et al.
Published: (2024-02-01) -
Long-Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder
by: Icro Maremmani, et al.
Published: (2023-08-01) -
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
by: Niraj R. Chavan, et al.
Published: (2017-10-01)